AbbVie Inc (ABBV)
179.54
-0.56
(-0.31%)
USD |
NYSE |
Jan 07, 14:52
AbbVie Research and Development Expense (TTM): 8.722B for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
Amgen Inc | 5.774B |
Gilead Sciences Inc | 8.104B |
Johnson & Johnson | 16.41B |
Eli Lilly and Co | 10.53B |
Merck & Co Inc | 22.98B |